Delivery Order SPE2DB25D3404-SPE2DB26FULVD
- Not listed
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 22, 2025, for the supply of Copaxone 40 mg/ml syringes. This firm fixed price delivery order, valued at $2,163.92, represents a competitive award with no set-aside designation and is scheduled for completion by September 23, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,218.86 to supply Copaxone 40 mg/mL syringes. This competitively awarded, firm fixed-price contract, issued on October 15, 2025, with an ultimate completion date of October 16, 2025, represents a direct fulfillment of pharmaceutical needs through the company's existing indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,943.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a direct procurement of pharmaceutical supplies to support federal medical needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the federal government, with particular emphasis on...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $14,769.02 by the Defense Logistics Agency (DLA) for the supply of Copaxone 20 mg/ml syringes. The contract, awarded on July 14, 2025, carries a completion date of July 15, 2025, and employs firm fixed pricing with no set-aside designation. The award was competitively conducted through an open procurement process, reflecting AmerisourceBergen's demonstrated capability to meet federal medical supply requirements. The place of...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,846.69 firm fixed-price delivery order is for the supply of Copaxone 40 mg/mL syringes, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML SYRINGEML. The contract has a ceiling value of $1,583.28 and an ultimate completion date of September 25, 2024. The contract is a firm fixed price delivery order and is not set aside for any preference program. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,583.28 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is to supply COPAXONE 40 MG/ML syringes, a specialty pharmaceutical product, with a period of performance through July 29, 2024. This order is placed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999, to provide a wide range of medical...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULVDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Copaxone 40 mg/mL syringes with a firm fixed price ceiling value of $2,645.73. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to compete openly for federal medical procurement needs. The delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen's consistent receipt of non-set-aside, competitively awarded delivery orders demonstrates its established capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 10/27/25 |